ALC Stock Recent News
ALC LATEST HEADLINES
Strong growth in the Surgical and Vision Care businesses raises investors' optimism for ALC.
Bausch + Lomb stock surged Monday — briefly breaking out — on a report the company is working with advisors to explore a potential sale.
Alcon Inc. ALC reported mixed second-quarter results, after the closing bell on Tuesday.
Alcon CEO David Endicott comments on the company's second-quarter results.
Alcon Inc. (NYSE:ALC ) Q2 2024 Earnings Conference Call August 21, 2024 8:00 AM ET Company Participants Dan Cravens - Vice President, Investor Relations David Endicott - Chief Executive Officer Tim Stonesifer - Chief Financial Officer Conference Call Participants Jeff Johnson - Baird Graham Doyle - UBS Veronika Dubajova - Citi Ryan Zimmerman - BTIG David Adlington - JPMorgan Patrick Wood - Morgan Stanley Jack Reynolds-Clark - RBC Capital Markets David Saxon - Needham & Company Anthony Petrone - Mizuho Group Larry Biegelsen - Wells Fargo Michael Sarcone - Jefferies Issie Kirby - Redburn Atlantic Richard Felton - Goldman Sachs Tom Stephan - Stifel Steven Lichtman - Oppenheimer & Company Brett Fishbin - KeyBanc Capital Markets Operator Greetings and welcome to the Alcon Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Alcon (ALC) delivers impressive growth in Implantables and Contact Lenses in the second quarter of 2024.
The headline numbers for Alcon (ALC) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
GENEVA--(BUSINESS WIRE)--Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses.
GENEVA--(BUSINESS WIRE)--Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses.
Alcon (ALC) is witnessing growth in its over-the-counter portfolio, driven by favorable pricing and a sustained family of products.